Literature DB >> 16000336

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Glenda M Halliday1, Anita Ophof, Melissa Broe, Poul H Jensen, Emma Kettle, Heidi Fedorow, Michael I Cartwright, Francine M Griffiths, Claire E Shepherd, Kay L Double.   

Abstract

The distribution and tempo of neuronal loss in Parkinson's disease correlates poorly with the characteristic and more widely spread intracellular changes associated with the disease process (Lewy bodies and Lewy neurites). To determine early intracellular changes in regions where cell loss is most marked (dopaminergic A9 substantia nigra) versus regions with Lewy bodies but where cell loss is limited, we assessed 13 patients with definite Parkinson's disease at various disease stages in comparison with controls. Using immunohistochemistry for alpha-synuclein, we confirmed the concentration of this protein in the soma of normal A9 neurons and in Lewy body pathology in brainstem catecholamine neurons in Parkinson's disease. Analysis of the degree of cell loss in brainstem catecholamine cell groups revealed that only the A9 substantia nigra had consistent significant cell loss early in the disease course with greater A9 cell loss correlating with increasing disease duration. To assess the earliest intracellular changes differentiating neurons more likely to degenerate, pigmented A9 and A10 neurons with and without obvious pathology were targeted, cell size and pigment density measured, and intracellular changes in alpha-synuclein location and lipid components analysed at both the light and electron microscope levels. There were no changes observed in healthy A10 neurons in Parkinson's disease compared with controls. Pigmented A9 neurons in later stages of degeneration with obvious Lewy body formation had a significant reduction in intracellular pigment, as previously described. In contrast, A9 neurons of normal morphological appearance and no characteristic pathology in Parkinson's disease exhibited significantly increased pigment density associated with a concentration of alpha-synuclein to the lipid component of the pigment and a loss of associated cholesterol. These changes in vulnerable but apparently healthy A9 neurons occurred without any change in cell size or in the amount of intracellular pigment compared with controls. The increase in pigment density is consistent with previously reported increases associated with oxidation and iron loading, reactions known to precipitate alpha-synuclein. The selectivity of the changes observed in A9 nigral neurons suggests that these early intracellular changes predispose these neurons to more rapid cell loss in Parkinson's disease. The increased concentration of neuronal alpha-synuclein and pigment in normal A9 neurons may already predispose these neurons to precipitate alpha-synuclein around pigment-associated lipid under oxidative conditions. Overall, these changes may trigger a cascade of events leading to larger intracellular aggregates of alpha-synuclein and the dispersement of protective pigment to precipitate cell death in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000336     DOI: 10.1093/brain/awh584

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  65 in total

1.  Investigation of the lipid component of neuromelanin.

Authors:  H Fedorow; R Pickford; E Kettle; M Cartwright; G M Halliday; M Gerlach; P Riederer; B Garner; K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-05-26       Impact factor: 3.575

Review 2.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 3.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

4.  Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking.

Authors:  Bong-Kyu Choi; Mal-Gi Choi; Jae-Yeol Kim; Yoosoo Yang; Ying Lai; Dae-Hyuk Kweon; Nam Ki Lee; Yeon-Kyun Shin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 5.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

6.  APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease.

Authors:  Neeraj Kumar Singh; Basu Dev Banerjee; Kiran Bala; Aldrin Anthony Dung Dung; Neelam Chhillar
Journal:  Neurol Sci       Date:  2014-02-07       Impact factor: 3.307

7.  Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.

Authors:  Sian Genoud; Blaine R Roberts; Adam P Gunn; Glenda M Halliday; Simon J G Lewis; Helen J Ball; Dominic J Hare; Kay L Double
Journal:  Metallomics       Date:  2017-10-18       Impact factor: 4.526

8.  Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease.

Authors:  Mónica Tomás; Emma Martínez-Alonso; Narcisa Martínez-Martínez; Mireia Cara-Esteban; José A Martínez-Menárguez
Journal:  Histol Histopathol       Date:  2020-10-20       Impact factor: 2.303

9.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

10.  Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle.

Authors:  Kristen A Malkus; Elpida Tsika; Harry Ischiropoulos
Journal:  Mol Neurodegener       Date:  2009-06-05       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.